Type 1 diabetes: treatment [sounds like]
409 results
101 - 200
Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
Diagnosis and treatment of childhood hypercholesterolaemia - Follow-up of type 1 diabetes
- No benefit to screening with CT angiography for asymptomatic CAD in adults with diabetes
Dietary advice for the prevention of type 2 diabetes mellitus in adults: Cochrane systematic review- High-dose B-vitamins harmful to patients with diabetic nephropathy
- Comprehensive treatment and follow-up of type 2 diabetes
- Metformin monotherapy for adults with type 2 diabetes mellitus
- Diabetes: definition, differential diagnosis and classification
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Insulin therapy in type 2 diabetes
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
- Hypoglycaemia in a patient with diabetes
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
- Fenofibrate for diabetic retinopathy
- Treatment of periodontitis for glycaemic control in people with diabetes mellitus
- Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
- Alpha‐lipoic acid for diabetic peripheral neuropathy
- Exercise and diet for preventing type 2 diabetes mellitus
- GLP-1 agonists + basal insulin better than glycemic control in T2DM
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Diabetic ketoacidosis
- Eye symptoms and signs of systemic diseases
- Uncertain if tight control reduces long-term mortality in patients with T1DM
- Glucose targets for preventing diabetic kidney disease and its progression
- Incretin-based therapy with dipeptidyl peptidase 4 inhibitors in type 2 diabetes
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Intensive glucose therapy during hospitalization for stroke does not improve functional outcomes (SHINE)
- Home glucose monitoring offers no benefit to patients not using insulin
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Gestational diabetes mellitus (GDM)
- J-shaped survival curve for glycemic control in patients with type 2 DM
- Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Dry eye syndrome
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- USPSTF 2017 does not recommend for or against screening for celiac disease in asymptomatic patients (I statement)
- Treatment of the diabetic foot
- Diabetic neuropathy
- AHA/ACC guideline for the primary prevention of stroke
- Incidental glucosuria in children
- Diet and exercise counseling does not reduce cardiovascular or all-cause mortality associated with prediabetes and type 2 diabetes
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- GLP-1 analogues for weight loss among patients with type 2 diabetes
- Severe hypoglycemic episodes raise risk of dementia in adults with T2DM
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Self-monitoring ineffective in patients with diabetes (ESMON)
- Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
- SGLT2 inhibitors, GLP1 agonists provide greater benefit for patients with type 2 diabetes
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Diabetic retinopathy
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
- ADA/EASD updated guidelines: glycemic control is only part of the management of type 2 diabetes
- Oral antidiabetic drugs and GLP-1 analogues
- Association of glycaemic control and complications of type 2 diabetes
- Proteinuria
- SGLT-2 inhibitors in type 2 diabetes
- Dietary advice and exercise for type 2 diabetes mellitus
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
- Ayurvedic treatments for diabetes mellitus: Cochrane systematic review
- Reducing cardiovascular events by multifactorial intervention in patients with type 2 diabetes
- Specialist nurses in diabetes mellitus: Cochrane systematic review
- NICE guidelines for diabetes mellitus, type 2
- Pentoxifylline for diabetic kidney disease
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Insulin added on metformin in type 2 diabetes
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Metabolic syndrome
- Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Air travel and illness
- Silver based wound dressings and topical agents for treating diabetic foot ulcers
- Intensive versus conventional glycaemic control for treating diabetic foot ulcers
- Hypothyroidism in children
- Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
- Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
- Risk of severe hypoglycemia similar between different insulin formulations
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
- GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Group based training for self-management strategies in people with type 2 diabetes mellitus
- Fenofibrate decreases amputation in patients with type 2 DM (FIELD)
- Metformin should be initial therapy for adults with type 2 DM